Table 4.

Serum and tissue biochemical values of the control and exposure groups.

Sample	Parameter	Group
		Control -male	Control -female	Exposure -male	Exposure -female
Serum	Hepatic function
	STP(g/dL)	49 ± 2	49 ± 4	55 ± 3	54 ± 3
	ALB(g/dL)	23.2 ± 0.8	24.3 ± 1.2	25.6 ± 1.5**	26.5 ± 0.7
	A/G	0.9 ± 0.1	1.0 ± 0.1	0.9 ± 0.0	1.0 ± 0.1
	TBIL(mg/dL)	1.2 ± 0.4	0.6 ± 0.7	0.8 ± 0.6	1.0 ± 0.3
	DBIL(mg/dL)	0.4 ± 0.3	0.1 ± 0.6	0.4 ± 0.3	0.1 ± 0.1
	ALT(IU/L)	64 ± 8	65 ± 7	42 ± 9**	53 ± 1
	ALP(IU/L)	282 ± 24	163 ± 5	225 ± 41	158 ± 7*
	GGT(IU/L)	0.4 ± 1.1	1.3 ± 1.5	0.8 ± 0.4	1.5 ± 0.7
	ASTm(IU/L)	45 ± 8	29 ± 12	26 ± 14*	42 ± 4
	AST(IU/L)	165 ± 36.	139 ± 27	144 ± 41	171 ± 18
	LDH(IU/L)	1094 ± 276	497 ± 222	650 ± 228*	786 ± 98
	Renal function
	CREA (mg/dL)	19 ± 5	32 ± 1	24 ± 2	29 ± 1*
	UREA(mmol/dL)	6.6 ± 0.3	5.4 ± 0.2	6.1 ± 0.5	7.4 ± 0.1**
	GLU (mg/dL)	17.4 ± 2.0	21.1 ± 8.8	14.8 ± 3.3	17.7 ± 1.3
	UA (μmol/dL)	225 ± 22	211 ± 144	149 ± 22*	1 01 ± 9
	RBP(mg/L)	0.4 ± 1.9	1.7 ± 2.1	1.2 ± 2.0	3.0 ± 1.4
	CysC(mg/L)	0.19 ± 0.01	0.18 ± 0.01	0.18 ± 0.01	0.16 ± 0.07*
	Cardiovascular function
	CK (IU/L)	4150 ± 2058	2456 ± 1803	3184 ± 1528
	CK-MB (IU/L)	1030 ± 144	526 ± 164	968 ± 148
	ACE (IU/L)	288 ± 18.0	271.7 ± 11.0	294.2 ± 15.1
	Thyroid function
	TT3 (ng/dL)	0.8 ± 0.1	0.8 ± 0.1	0.8 ± 0.0	0.8 ± 0.0
	TT4 (ng/dL)	37.8 ± 5.2	40.5 ± 12.6	37.2 ± 1.8	36.7 ± 0.0
	FT3 (ng/dL)	3.1 ± 0.4	3.1 ± 0.6	3.2 ± 0.3	2.9 ± 0.0
	FT4 (ng/dL)	11.2 ± 1.9	11.8 ± 1.0	12.4 ± 0.9	11.6 ± 0.0
	Oxidative stress
Serum	SOD(IU/L)	277 ± 36.7	149.7 ± 31.5	148.2 ± 51.5**	179.5 ± 31.8
Lung tissue	MDA (nmol/mg)	27.0 ± 2.8	24.8 ± 2.5	34.5 ± 4.3*	31.8 ± 0.1*

Values represent the mean ± SEM, n = 15. Control-male vs. Exposure-male, Control-female vs. Exposure-female, * P < 0.05. * *P < 0.01.